The Technical Analyst
Virtus LifeSci Biotech [BBP]
Exchange: NYSE
Virtus LifeSci Biotech Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $55.65
America/New_York / 7 mai 2024 @ 10:50
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 18.55 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 0.333 mill |
| Avg Daily Volume: | 0.0029 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 54.65 - 56.27 ( +/- 1.45%) |
| ATR Model: 14 days |
Forecast:
12:30 - $55.55
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $55.65 (0.00% ) |
| Volume | 0.0004 mill |
| Avg. Vol. | 0.0029 mill |
| % of Avg. Vol | 13.18 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BBP
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BBP
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Last 10 Buy Signals
Latest News
2024-01-09 12:47:21 - Zacks Investment Research
Biotech ETFs Stage Solid Comeback at the Start of 2024
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.
2023-02-15 14:18:10 - Zacks Investment Research
5 Least-Hurt Biotech ETFs of the Last Week
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
2023-01-11 18:09:00 - Seeking Alpha
Can Health Care Stocks Outperform Again In 2023?
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
2022-12-06 14:18:05 - Zacks Investment Research
2 Sector ETFs Hovering Around a 52-Week High
We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.
2022-09-27 09:02:07 - Zacks Investment Research
5 Best Areas of Q3 of 2022 & Their Top ETFs
2022-08-08 15:48:05 - Zacks Investment Research
Biotech & Crypto -- Best ETF Areas of Last Week
2022-08-05 21:42:37 - ETF Trends
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal
Biotechnology sector-related exchange traded funds continued to rally Friday on reports that Pfizer Inc. (NYSE: PFE) is looking to acquire Global Blood Therapeutics (NasdaqGS: GBT). On Friday, the Virtus LifeSci Biotech Products ETF (BBP) rose 1.8%, the SPDR S&P Biotech ETF (XBI) increased 3.6%, and the ALPS Medical Breakthroughs ETF (SBIO) was up 3.9%.
2022-08-04 18:51:38 - ETF Trends
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics
Global Blood Therapeutics (NasdaqGS: GBT) shares climbed Thursday, lifting biotechnology sector-related exchange traded funds, on speculation of takeover bids for the small drug developer. On Thursday, the Virtus LifeSci Biotech Products ETF (BBP) rose 7.2%, the SPDR S&P Biotech ETF (XBI) increased 5.2%, and the ALPS Medical Breakthroughs ETF (SBIO) was up 5.1%.
2022-07-08 12:25:12 - Zacks Investment Research
5 ETFs Riding High on the Biotech Comeback
Biotech, the downtrodden segment of the market, has made a solid comeback on bargain hunting.
2022-07-05 21:16:34 - ETF Trends
Biotech ETFs Are Making a Comeback
Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech Clinical Trials ETF (BBC) gained 15.5%, the Virtus LifeSci Biotech Products ETF (BBP) rose 12.8%, the SPDR S&P Biotech ETF (XBI) increased 11.3% and the ALPS [.